Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model

MLA

Manabu Fujisawa, et al. “Tet2 Deficiency in Immune Cells Exacerbates Tumor Progression by Increasing Angiogenesis in a Lung Cancer Model.” Cancer Science, vol. 112, no. 12, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....834f1154b1e73da23036c9a624c7dcec&authtype=sso&custid=ns315887.

APA

Manabu Fujisawa, Yasuhito Suehara, Shigeru Chiba, Kota Fukumoto, Masayuki Noguchi, Ryota Matsuoka, Mamiko Sakata-Yanagimoto, Yen T. M. Nguyen, Daisuke Matsubara, Keiichiro Hattori, Tran B. Nguyen, Yoshiaki Abe, & Tatsuhiro Sakamoto. (2021). Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model. Cancer Science, 112(12).

Chicago

Manabu Fujisawa, Yasuhito Suehara, Shigeru Chiba, Kota Fukumoto, Masayuki Noguchi, Ryota Matsuoka, Mamiko Sakata-Yanagimoto, et al. 2021. “Tet2 Deficiency in Immune Cells Exacerbates Tumor Progression by Increasing Angiogenesis in a Lung Cancer Model.” Cancer Science 112 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....834f1154b1e73da23036c9a624c7dcec&authtype=sso&custid=ns315887.